Six Steps to Mastering Pharmacovigilance Signal Detection

The ability to thoroughly and efficiently categorize and assess signals that are received in your pharmacovigilance program is critical to ensuring patient safety and adherence to global regulatory requirements. Have you mastered the six steps?

First page of UBC's infographic for signal detection and management

Signal management is a critical process in pharmacovigilance for both products in clinical development and for already marketing products, for the proactive and timely identification of potential new risks or signals. Are you able to take your safety signals from detection through assessment, action, and recommendation? Download our step-by-step guide today.

Explore the nuances associated with signal detection and management from the UBC’s leading safety scientists Master the five steps below:

  • Signal Detection
  • Signal Validation
  • Signal Prioritization
  • Actions Recommendation

UBC combines a depth of experience in pharmacovigilance, risk management, and safety signal detection and assessment with innovative, purpose-built technology systems to provide you with the insights you need to oversee the safety of your product. For more information on UBC’s pharmacovigilance services, visit here.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.